The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Claudin18.2 (CLDN18.2) expression and efficacy in pancreatic ductal adenocarcinoma (PDAC): Results from a phase I dose expansion cohort evaluating IBI343.
 
Xianjun Yu
No Relationships to Disclose
 
Jieer Ying
No Relationships to Disclose
 
Li Enxiao
No Relationships to Disclose
 
Aiping Zhou
Consulting or Advisory Role - BeiGene Beijing
 
Yuping Sun
Honoraria - AstraZeneca; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Roche
Research Funding - Pfizer; Roche
 
Jinbo Yue
No Relationships to Disclose
 
Jian Ruan
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Lin Shen
No Relationships to Disclose
 
Juan Du
No Relationships to Disclose
 
Andrea Tazbirkova
Research Funding - Antengene; Arcus Biosciences; BeiGene; Checkpoint Therapeutics; Janssen-Cilag; Novotech
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Lilly; MSD; Pierre Fabre; Roche
 
Jia Liu
Honoraria - MSD; Specialised Therapeutics
Consulting or Advisory Role - Greywolf Therapeutics (Inst); Starpharma (Inst); Taiho Pharmaceutical
Research Funding - Abbvie (Inst); ALX Oncology (Inst); AVEO (Inst); AVEO (Inst); Bayer (Inst); Bristol Ms Squibb (Inst); Bristol-Myers Squibb (Inst); Carina Biotech (Inst); Corvus Pharmaceuticals (Inst); Greywolf Therapeutics (Inst); IDEAYA Biosciences (Inst); ImmVirX (Inst); Innovent Biologics (Inst); Merus (Inst); MSD (Inst); Nested Therapeutics (Inst); Regeneron (Inst); Relay Therapeutics (Inst); Starpharma (Inst)
Travel, Accommodations, Expenses - ImmVirX; Innovent Biologics; MSD; Starpharma
 
Yanru Qin
No Relationships to Disclose
 
Michelle Morris
Travel, Accommodations, Expenses - MSD
 
Zhihua Li
No Relationships to Disclose
 
Meili Sun
No Relationships to Disclose
 
Yueyin Pan
No Relationships to Disclose
 
Jun Zhang
No Relationships to Disclose
 
Yingmei Guo
Employment - Innovent Biologics
Stock and Other Ownership Interests - Innovent Biologics
 
Hui Zhou
Employment - Innovent Biologics
Stock and Other Ownership Interests - Innovent Biologics